Evidence map›Paper›PMID 42703177›Full record

ArticleMicroRNA (Shariqah, United Arab Emirates)2026

Corrigendum to: Bone Marrow Mesenchymal Stem Cells Overexpressing MicroRNA-126 to Treat Critical Limb Ischemia.

Pegah Nammian, Seyedeh-Leili Asadi-Yousefabad, Seyyed Sajad Daneshi, Jafar Fallahi, Sahar Khajeh, Seyed Mohammad Bagher Tabei, Vahid Razban

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in MicroRNA (Shariqah, United Arab Emirates), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Pegah NammianDepartment of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyedeh-Leili Asadi-YousefabadDepartment of Molecular Medicine, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran.
Seyyed Sajad DaneshiPostdoctoral Researcher, Stem Cells Technology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Jafar FallahiDepartment of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.
Sahar KhajehBone and Joint Disease Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Seyed Mohammad Bagher TabeiDepartment of Genetics, Shiraz University of Medical Sciences, Shiraz, Iran.
Vahid RazbanDepartment of Molecular Medicine, School of Advanced Medical Sciences and Technologies, Shiraz University of Medical Sciences, Shiraz, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the published version of this article [1], an overlap discrepancy was identified in some of the slides in Fig. (7). This error was unintentional and occurred during the manuscript preparation stage by the authors. This correction does not affect the study's quantitative analyses, results, or conclusions. The authors apologize for this error and any inconvenience it may have caused. The original article can be found online at: https://www.eurekaselect.com/article/146623 The authors apologizes for this oversight and any inconvenience caused to the readers.

Identifiers

PMID42703177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.